Monthly Archives: November 2017


SPECIAL REPORT: FDA 2013 – 2017 Drug GMP Warning Letters

This Special Report presents a detailed summary and trends of FY2017 FDA drug GMP warning letters from fiscal years 2013 through 2017. Appendices 1 - 5 provide tabulations of warning letters from each of five fiscal years and identify product type covered in the letter, the issuing office, number of deficiencies identified, and the country in which the sites in [...]

By |2018-04-01T21:30:40+00:00November 27th, 2017|Special Reports|